Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5604]
News [13558]
Articles [218]
Editorials [5]
Conferences [266]
elearning [17]

New agents and mTOR inhibitors

Dr David Sabatini – Whitehead Institute, Boston, USA
New agents and mTOR inhibitors ( Dr David Sabatini – Whitehead Institute, Boston, USA )
7 Dec 2012

Young women with breast cancer more likely to respond to neoadjuvant chemotherapy

Prof Sibylle Loibl - University of Frankfurt, Frankfurt, Germany
Young women with breast cancer more likely to respond to neoadjuvant chemotherapy ( Prof Sibylle Loibl - University of Frankfurt, Frankfurt, Germany )
6 Dec 2012

Chemo after complete surgical removal of local or regional breast cancer recurrence increases survival rates

Dr Stefan Aebi - Luzerner Kantonsspital, Luzern, Switzerland
Chemo after complete surgical removal of local or regional breast cancer recurrence increases survival rates ( Dr Stefan Aebi - Luzerner Kantonsspital, Luzern, Switzerland )
6 Dec 2012

Fewer, bigger doses of radiotherapy benefit cancer patients

Prof John Yarnold - Institute of Cancer Research and Royal Marsden Hospital, UK
Fewer, bigger doses of radiotherapy benefit cancer patients ( Prof John Yarnold - Institute of Cancer Research and Royal Marsden Hospital, UK )
6 Dec 2012

Colon cancer microenvironments preventing invasion and metastasis

Dr Makoto Mark Taketo – Kyoto University Graduate School of Medicine, Japan
Colon cancer microenvironments preventing invasion and metastasis ( Dr Makoto Mark Taketo – Kyoto University Graduate School of Medicine, Japan )
20 Nov 2012

Mechanisms of the tumour microenvironment and inflammation

Dr Alberto Mantovani – University of Milan, Italy
Mechanisms of the tumour microenvironment and inflammation ( Dr Alberto Mantovani – University of Milan, Italy )
20 Nov 2012

Patient led funding for clinical trials

Dr Ian Lewis – Tenovus, Cardiff, UK
Patient led funding for clinical trials ( Dr Ian Lewis – Tenovus, Cardiff, UK )
15 Nov 2012

Benefits of partaking in clinical trials

Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK
Benefits of partaking in clinical trials ( Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK )
15 Nov 2012

Advances in haemato-oncological treatment options

Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK
Advances in haemato-oncological treatment options ( Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK )
15 Nov 2012

Highlights from the 4th EUTROC meeting

Prof John Green – University of Liverpool, UK
Highlights from the 4th EUTROC meeting ( Prof John Green – University of Liverpool, UK )
15 Nov 2012

Development of clinical trials and biobanks

Prof Hani Gabra – Imperial College London, UK
Development of clinical trials and biobanks ( Prof Hani Gabra – Imperial College London, UK )
15 Nov 2012

The AKT pathway and chemotherapy resistant ovarian cancer

Dr Euan Stronach – Imperial College London, UK
The AKT pathway and chemotherapy resistant ovarian cancer ( Dr Euan Stronach – Imperial College London, UK )
15 Nov 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation